EnsoData adds acoustic flow and microphone data channels to enable an exciting new way to pre-screen patients for sleep apnea, allowing EnsoData to improve access and affordability in underserved sleep apnea patient populations.
EnsoData Announcements
Scroll below to find recent press releases around EnsoData’s FDA clearances, partnerships, research, fundraising, milestones, awards, and other noteworthy recognition
Partnership Announcement: AI software integration between EnsoData and Parachute Health aims to connect sleep disorder diagnosis to therapy prescription.
Aeroflow and EnsoData usher in a new era in personalized sleep apnea care, population health management, and patient coaching with AI-powered predictive analysis of CPAP monitoring data.
EnsoData announces its FDA-cleared diagnostic AI analysis and sleep scoring solution, EnsoSleep, earned stage-specific autoscoring software certification from the American Academy of Sleep Medicine (AASM).
EnsoData achieved FDA 510(k) clearance for groundbreaking technology that enables AI-powered sleep diagnosis using FDA-cleared pulse oximetry (pulse ox) devices.
EnsoData and React Health announced a strategic collaboration to optimize PAP adherence support for patients with sleep apnea using EnsoData’s AI technology.
EnsoData Ranks Among Highest-Scoring Businesses on Inc. Magazine’s 2023 List of Best Workplaces, marking third consecutive year on the list.
EnsoData Applies AI to Address Health Concerns for 1,000,000 Patients Worldwide, a milestone reached in May 2023.
EnsoData has appointed Dr. Nathaniel Watson as New Chief Medical Officer, expanding its clinical sleep expertise.
EnsoData’s new funding, coupled with new partnerships and an executive hire, promise rapid growth and accelerated delivery of its validated AI solution for sleep medicine.
EnsoData receives FDA 510(k) clearance of latest sleep center tools to enhance patient care and experience; expands into pediatrics and adds to home testing capabilities.
Cadwell partners with EnsoData with direct integrations to reduce manual data analysis performed by sleep clinicians using Cadwell devices.
EnsoData in the Press
More exciting, from my point of view, is how technology empowers patients. Editor Liz spoke with Sam Rusk at EnsoData about that company’s recent partnership with Aeroflow Health (see page 1) to use its predictive tools to identify patients struggling with therapy. By looking at data that includes everything from leaks to AHI, its technology…
EnsoData has acquired sleep testing diagnostic technology from Resonea, adding acoustic flow and microphone data channels to its platform as a new way to use a mobile application to pre-screen patients for sleep apnea and extend the diagnostic capabilities of home sleep testing
EnsoData Acquisition Brings Mobile Sleep Apnea Screening to Homes The sleep testing technology will allow patients to use their smartphones for preliminary sleep apnea screening at home, potentially expanding access to diagnostic services.
How cutting-edge research uses AI and Machine Learning (ML) to correlate multiple factors for a more robust understanding of sleep health.
VirtuOx Unveils Sleepifi, a Rebrand With New HST, Dental Platform The Sleepifi Dream is a type 4 home sleep testing device that uses high-resolution pulse oximetry and Ensosleep PPG analysis to detect sleep-disordered breathing and identify sleep stages, allowing patients to test for up to seven nights. Sleepifi Dental is a comprehensive system for dental…
EnsoData’s ePrescribing Integration with Parachute Simplifies Ordering Workflow and Accelerates Access to CPAP Therapy
‘WHEN YOU THINK ABOUT THIS PATIENT POPULATION, IT’S NOT VERY SYSTEMATIZED OR EASY TO UNDERSTAND AND WE WANT TO HELP WITH THAT.
PPG-Based AI to Detect Obstructive Sleep Apnea Shows No Bias Based on Skin Color — No significant differences between AI analysis and gold-standard polysomnography
AI software integration between EnsoData and Parachute Health aims to connect sleep disorder diagnosis to therapy prescription, improving access for patients, physicians alike
EnsoData and Aeroflow Health have announced a strategic partnership to use predictive clinical AI tools to enable more timely patient care, increase patient adherence and strengthen the provider-patient connection.
The EnsoData, Aeroflow partnership aims to provide personalized support and improve treatment adherence for patients using CPAP.
Multimedia
The below gallery includes photos for use by members of the media. For press inquiries or to reach out to our EnsoData team to schedule an interview, podcast guest, or with any other general inquiries at team@ensodata.com.
EnsoData Leadership Team Bios
“Be thoughtful, be mindful, and take your time in situations where bias could be present.”
Andrea Ramberg, RPSGT, CCSH EnsoData Clinical Director
![](https://www.ensodata.com/wp-content/uploads/2022/03/ensodata-party-pineapple-min.png)
Stay Up to Date
Learn More about EnsoSleep and Get Our Resources Delivered Straight to Your Inbox
"*" indicates required fields